Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Epilepsy | 134 | 121 | |
Seizures | 20 | 22 | |
Seizures (grand mal or tonic-clonic) | 9 | 7 | |
Seizures (absence or petit mal) | 7 | 5 | |
Myoclonic seizures | 2 | 4 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Dizziness | 6 | |
Fatigue | 6 | |
Tiredness | 6 | |
Depressed mood | 4 | |
Drowsiness | 4 | |
Excessive daytime sleepiness (somnolence) | 4 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 13 | |
Moderate | 37 | |
Mild | 53 | |
None | 34 |
Member evaluations
neuroplasticity
evaluated on Nov 29, 2012
- Perceived effectiveness for epilepsy: Moderate
- Side effects: Moderate
pokie too
evaluated on Nov 18, 2012
- Perceived effectiveness for Parkinson's disease: Moderate
- Side effects: Severe
whinni
evaluated on Oct 20, 2011
- Perceived effectiveness for epilepsy: Slight
- Side effects: None